Jerome Birnbaum
Direttore/Membro del Consiglio presso ASM Resources, Inc.
Profilo
Jerome Birnbaum founded Sopherion Therapeutics LLC in 2002 and Achillion Pharmaceuticals, Inc. in 2000, where he worked as Vice President.
Dr. Birnbaum also currently works at ASM Resources, Inc., as Director.
Dr. Birnbaum also formerly worked at New Brunswick Scientific Co., Inc., as Director from 2000 to 2007, Robert Wood Johnson University Hospital, Inc., as Director, Merck & Co., Inc., as Vice President, Vicuron Pharmaceuticals LLC, as Consultant, Sunesis Pharmaceuticals, Inc., as Consultant, Harvard University, as Advisor, Bristol-Myers Squibb Co., as Senior Vice President, Esperion Pharmaceuticals, Inc., as Consultant, and Diversity, Inc., as Consultant.
Dr. Birnbaum received his undergraduate degree in 1961 from Brooklyn College and graduate degree and doctorate degree from The University of Cincinnati College of Medicine.
Posizioni attive di Jerome Birnbaum
| Società | Posizione | Inizio |
|---|---|---|
ASM Resources, Inc.
 ASM Resources, Inc. Investment ManagersFinance ASM Resources Inc (ASM Resources) is a venture capital subsidiary of American Society for Microbiology founded in 2000. The firm is headquartered in Washington, District of Columbia. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Jerome Birnbaum
| Società | Posizione | Fine |
|---|---|---|
New Brunswick Scientific Co., Inc.
 New Brunswick Scientific Co., Inc. Medical SpecialtiesHealth Technology New Brunswick Scientific Co., Inc. manufactures and designs research equipment and bioreactors. The company was founded in 1946 and is headquartered in Edison, NJ. | Direttore/Membro del Consiglio | 26/09/2007 |
| Diversity, Inc. /US/ | Consulente / Consigliere | - |
| Esperion Pharmaceuticals, Inc. | Consulente / Consigliere | - |
| VIRACTA THERAPEUTICS, INC. | Consulente / Consigliere | - |
Vicuron Pharmaceuticals LLC
 Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Consulente / Consigliere | - |
Formazione di Jerome Birnbaum
| Brooklyn College | Undergraduate Degree |
| The University of Cincinnati College of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| Aziende private | 10 |
|---|---|
New Brunswick Scientific Co., Inc.
New Brunswick Scientific Co., Inc. Medical SpecialtiesHealth Technology New Brunswick Scientific Co., Inc. manufactures and designs research equipment and bioreactors. The company was founded in 1946 and is headquartered in Edison, NJ. | Health Technology |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Health Technology |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
Sopherion Therapeutics LLC
 Sopherion Therapeutics LLC BiotechnologyHealth Technology Sopherion Therapeutics LLC develops and commercializes anti-cancer therapies. The company was founded by Ronald H. Goldfarb and Salvatore Forenza in 2002 and is headquartered in Princeton, NJ. | Health Technology |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Robert Wood Johnson University Hospital, Inc.
 Robert Wood Johnson University Hospital, Inc. Medical/Nursing ServicesHealth Services Robert Wood Johnson University Hospital is one of the academic medical centers. It provides state-of-the-art care across the full range of health care services. Its specialties include cardiac care from screening to heart surgery and transplantation, cancer care, emergency medicine, pediatrics, and maternal-fetal medicine. The hospital was founded in 1884 and is located in New Brunswick, NJ. | Health Services |
ASM Resources, Inc.
ASM Resources, Inc. Investment ManagersFinance ASM Resources Inc (ASM Resources) is a venture capital subsidiary of American Society for Microbiology founded in 2000. The firm is headquartered in Washington, District of Columbia. | Finance |
| Bristol-Myers Squibb Co. /MENA Branded Generics Bus/ | Health Technology |
| Esperion Pharmaceuticals, Inc. | |
| Diversity, Inc. /US/ |
- Borsa valori
- Insiders
- Jerome Birnbaum
